The historical rank and industry rank for Dhanvantri Jeevan Rekha's FCF Margin % or its related term are showing as below:
BOM:531043'
s FCF Margin % Range Over the Past 10 Years
Min: -18.5 Med: 0.16 Max: 12.56
Current: 3.39
During the past 13 years, the highest FCF Margin % of Dhanvantri Jeevan Rekha was 12.56%. The lowest was -18.50%. And the median was 0.16%.
BOM:531043's FCF Margin % is ranked better than 50.37% of 667
companies
in the Healthcare Providers & Services industry
Industry Median: 3.1
vs BOM:531043: 3.39
Dhanvantri Jeevan Rekha FCF Margin % Related Terms
Dhanvantri Jeevan Rekha FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:531043 vs HCA, THC, DVA: FCF Margin % Comparison
For the Medical Care Facilities subindustry, Dhanvantri Jeevan Rekha's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dhanvantri Jeevan Rekha FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dhanvantri Jeevan Rekha's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Dhanvantri Jeevan Rekha's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dhanvantri Jeevan Rekha (BOM:531043) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Dhanvantri Jeevan Rekha and its competitors. According to the industry distribution chart, Dhanvantri Jeevan Rekha ranks #331 out of 667 companies in the Healthcare Providers & Services industry, placing it in the top 49.6%.
Is Dhanvantri Jeevan Rekha's FCF Margin % too high?
Dhanvantri Jeevan Rekha's current FCF Margin % is 0.00%. Based on the distribution chart, Dhanvantri Jeevan Rekha ranks #331 out of 667 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Dhanvantri Jeevan Rekha has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dhanvantri Jeevan Rekha's FCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dhanvantri Jeevan Rekha ranks #331 out of 667 companies for FCF Margin %. This puts Dhanvantri Jeevan Rekha in the upper half of its industry. The industry median FCF Margin % is 3.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.10, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Dhanvantri Jeevan Rekha and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dhanvantri Jeevan Rekha's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dhanvantri Jeevan Rekha stock overvalued right now?
Based on GuruFocus' analysis, Dhanvantri Jeevan Rekha (BOM:531043) is currently considered Fairly Valued. The stock's GF Value™ is ₹24.87, compared to a current price of ₹26.45 — trading 6.4% above its estimated fair value. The current FCF Margin % is 0.00%. Dhanvantri Jeevan Rekha's overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Dhanvantri Jeevan Rekha (BOM:531043), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dhanvantri Jeevan Rekha (BOM:531043) Overvalued in 2026?
Based on GuruFocus' analysis, Dhanvantri Jeevan Rekha stock appears to be overvalued.
The current stock price of ₹26.45 is trading 6.4% above its estimated GF Value™ of ₹24.87.
GuruFocus considers Dhanvantri Jeevan Rekha to be Fairly Valued.
Key valuation signals for BOM:531043:
FCF Margin %: 0.00%
GF Value™: ₹24.87 vs. price of ₹26.45 (6.4% above fair value)
No single metric tells the full story. See the BOM:531043 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dhanvantri Jeevan Rekha Ltd is engaged in providing diagnostic and therapeutic services and has extended its scope of diagnostic and hospital services by providing a fully operational Cath Lab, catering to higher end needs of the cardiac patients including Angiography, Angioplasty, Pacemaker Implantation, Valvuloplasty etc. The hospital has expanded its services to include a wide range of specialties such as Cardiology, Neurology, Orthopedics, Radiology, Gastroenterology, General Surgery, Urology, and General Medicine.
56GF Score
Get the complete analysis for BOM:531043
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:531043 has been successfully added to your 
